C3i
Biotechnology Research
C3i is a leading full-service Contract Development and Manufacturing Organization (CDMO) that offers a wide range of services from process development and GMP manufacturing to QC analytical development, biomarker development, immune monitoring, and CRO. Based in Montreal, Canada, this innovative company provides an integrated structure for the development, translation, and commercialization of some of the most cutting-edge therapies available. C3i's mission is to offer its clients a "one-stop-shop" solution for the development, translation, and commercialization of their products. With a GMP Manufacturing Unit for Cell and Gene therapies, in-house testing QC, biomarker-diagnostic, and test development capabilities, as well as clinical research services that include KOLs, protocol development, and key patient access, C3i also provides investment and support for innovative companies. C3i is a valuable partner for drug development companies looking to bring their products to market quickly and efficiently.
Headquarters
Montreal, Québec
Website
http://centrec3i.comIndustry
Biotechnology Research
Year of foundation
2016
Company size
51-200 employees
Benefits
- Comprehensive services from process development to commercialization.
- State-of-the-art GMP Manufacturing Unit for Cell and Gene therapies.
- In-house testing QC and biomarker-diagnostic capabilities.
- Clinical research services with KOLs and patient access.
- Investment and support for innovative companies.
Contact info
Hôpital Maisonneuve-Rosemont, Pavillon Rachel Tourigny, 5415 Boulevard de l'Assomption, Montreal, Québec H1T 2M4, CA